Company intelligence / Profile preview
Avontec
Martinsried, Bavaria, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
Avontec was a German biopharmaceutical company specializing in the development of oligonucleotide-based therapeutics for inflammatory and respiratory diseases. The company's core technology centered on transcription factor decoys (TFDs), which are designed to inhibit the activity of specific transcription factors like NF-kappaB and AP-1. Its lead candidate, AVN-101, was evaluated in clinical trials for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Founded in the late 1990s and backed by prominent venture capital firms, Avontec was a pioneer in the decoy oligonucleotide space before ceasing operations.
- Therapeutic areas
- PulmonologyDermatology
- Modalities
- Synthetic oligonucleotideBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Avontec.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avontec.